共 50 条
Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity
被引:10
|作者:
Wan Yin Winnie Yeung
[1
]
Park, Hae Sim
[2
]
机构:
[1] Pamela Youde Nethersole Eastern Hosp, Dept Internal Med, Div Rheumatol, Hong Kong, Peoples R China
[2] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Med Ctr, 164 World Cup Ro, Suwon 16499, South Korea
关键词:
NSAID;
asthma;
hypersensitivity;
urticaria;
angioedema;
rhinitis;
IMMEDIATE-TYPE HYPERSENSITIVITY;
CUTANEOUS ADVERSE-REACTIONS;
CHRONIC RHINOSINUSITIS;
ASPIRIN DESENSITIZATION;
NSAIDS HYPERSENSITIVITY;
BASOPHIL ACTIVATION;
OMALIZUMAB;
DIAGNOSIS;
ASTHMA;
THERAPY;
D O I:
10.3349/ymj.2020.61.1.4
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The clinical phenotypes of nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity are heterogeneous with various presentations including time of symptom onset, organ involvements, and underlying pathophysiology. I laving a correct diagnosis can be challenging. Understanding their respective mechanisms as well as developing a comprehensive classification and diagnostic algorithm are pivotal for appropriate management strategy. Treatment modalities are based on the subtypes and severity of hypersensitivity reactions. Insights into the phenotypes and endotypes of hypersensitivity reactions enable personalized management in patients with suboptimal control of disease. This review updated the recent evidence of pathophysiology, classification, diagnostic algorithm, and management of NSAID hypersensitivity reactions.
引用
收藏
页码:4 / 14
页数:11
相关论文